ISRCTN18466386已完成未知
Breast Cancer in Remission: A Randomised Trial of Follow-Up
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Previously diagnosed carcinoma of the breast stages I - III
- •3. Primary treatment, including complications, completed at least 3 months ago.
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
1 期
Study to see if it is possible to guide tumorectomy in case of breast cancer by near-infrared fluorescence after intravenous injection of Indocyanine GreeImaging of tumours and their margins after intravenous injection ofIndocyanine Green to breast cancer patientsEUCTR2014-003268-19-BEJules Bordet Institute
撤回
不适用
A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomesCancer - BreastPublic Health - Health service researchBreast cancerACTRN12615000197538A/Prof Suzanne Robinson130
已完成
不适用
Randomised controlled trial in breast cancer genetic counselingGenetic counseling, web-based tailored info, communication, breast cancerBreast cancer genetic counselingCancerISRCTN82643064etherlands Institute for Health Services Research (NIVEL) (The Netherlands)200
招募中
不适用
Clinical performance study of breast cancer prognostic diagnosticsGenesWell™ BCT in Korean patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancerKCT0004263Samsung Medical Center500
进行中（未招募）
不适用
This is a trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced ER-, PR- and HER2- breast cancermetastatic or recurrent locally advanced breast cancer thatis ER-, PR- (or unknown) and HER2- or known BRCA1/BRCA2 carriers.MedDRA version: 13.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-004470-26-GBThe Institute of Cancer Research450